JPH027576B2 - - Google Patents

Info

Publication number
JPH027576B2
JPH027576B2 JP58034675A JP3467583A JPH027576B2 JP H027576 B2 JPH027576 B2 JP H027576B2 JP 58034675 A JP58034675 A JP 58034675A JP 3467583 A JP3467583 A JP 3467583A JP H027576 B2 JPH027576 B2 JP H027576B2
Authority
JP
Japan
Prior art keywords
tryptophan
composition according
sugar
carbohydrate
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58034675A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58201715A (ja
Inventor
Jei Urutoman Richaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of JPS58201715A publication Critical patent/JPS58201715A/ja
Publication of JPH027576B2 publication Critical patent/JPH027576B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58034675A 1982-03-08 1983-03-04 睡眠の向上方法 Granted JPS58201715A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35596782A 1982-03-08 1982-03-08
US355967 1982-03-08

Publications (2)

Publication Number Publication Date
JPS58201715A JPS58201715A (ja) 1983-11-24
JPH027576B2 true JPH027576B2 (enExample) 1990-02-19

Family

ID=23399528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58034675A Granted JPS58201715A (ja) 1982-03-08 1983-03-04 睡眠の向上方法

Country Status (4)

Country Link
EP (1) EP0088621A3 (enExample)
JP (1) JPS58201715A (enExample)
CA (1) CA1204666A (enExample)
GR (1) GR78505B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6866874B2 (en) * 2000-05-26 2005-03-15 Susan P. Hudson Tryptophan source from plants and uses therefor
JP4933097B2 (ja) 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
US4210637A (en) * 1978-07-31 1980-07-01 Massachusetts Institute Of Technology Composition and method for suppressing appetite for calories as carbohydrates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS *

Also Published As

Publication number Publication date
CA1204666A (en) 1986-05-20
EP0088621A3 (en) 1984-07-04
GR78505B (enExample) 1984-09-27
EP0088621A2 (en) 1983-09-14
JPS58201715A (ja) 1983-11-24

Similar Documents

Publication Publication Date Title
Lipton et al. Caffeine in the management of patients with headache
JPH0367663B2 (enExample)
Drewnowski et al. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters
EP3654963A1 (en) S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same
US20080293698A1 (en) Methods and Compositions for Treating Arg
JP2002512978A (ja) ニコチン含有溶液
AU2002224525B2 (en) Compositions for regulating desire for smoking
JP2904655B2 (ja) 抗ストレス剤
RU2160589C1 (ru) Средство для снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома и способ снижения алкогольного опьянения, предупреждения и снятия алкогольной интоксикации и похмельного синдрома с использованием этого средства
AU612106B2 (en) Therapeutic composition
Drewnowski Metabolic determinants of binge eating
Russ et al. Antidepressants and weight gain
RU2143901C1 (ru) Противокашлевая композиция, содержащая противокашлевое средство и бензидамин
US6066664A (en) Method for decreasing the appetite in bulimic, overweight individuals
EP1061925B1 (en) Combination of a gaba-a alpha 5 inverse agonist and a nicotinic agonist
Pedersen Treatment of nocturnal asthma in children with a single dose of sustained‐release theophylline taken after supper
JPS58201715A (ja) 睡眠の向上方法
WO2014128661A1 (en) Oral formulation and suspension of an oncology drug
Khandelwal et al. Anti-epileptic drugs (AEDs)
FR2886154A1 (fr) Composition pour retarder le developpement de la maladie d'alzheimer
JP7506371B2 (ja) ドーパミン減少抑制剤
RU2703293C1 (ru) Жидкая лекарственная форма для перорального введения, обладающая ноотропной активностью
JP4831540B2 (ja) 経口催眠剤及び催眠性飲食物
JP2003171286A (ja) 抗ストレス剤
RU2546300C1 (ru) Композиция, обладающая действием на центральную нервную систему и ее применение